Literature DB >> 19997888

Topoisomerase I-mediated DNA relaxation as a tool to study intercalation of small molecules into supercoiled DNA.

Paul Peixoto1, Christian Bailly, Marie-Hélène David-Cordonnier.   

Abstract

Several biochemical and biophysical methods are available to study the intercalation of a small molecule between two consecutive base pairs of DNA. Among them, the topoisomerase I-mediated DNA relaxation assay has proved highly efficient, relatively easy to handle and very informative to investigate drug binding to DNA. The test relies on the use of a supercoiled plasmid to mimic the topological constraints of genomic DNA. The three main components of the assay - the topoisomerase I enzyme, DNA helix and intercalating small molecules - are presented here in a structural context. The principle of the assay is described in detail, along with a typical experimental protocol.

Mesh:

Substances:

Year:  2010        PMID: 19997888     DOI: 10.1007/978-1-60327-418-0_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Triggering autophagic cell death with a di-manganese(II) developmental therapeutic.

Authors:  Creina Slator; Zara Molphy; Vickie McKee; Andrew Kellett
Journal:  Redox Biol       Date:  2017-02-04       Impact factor: 11.799

Review 2.  Targeting Transcription Factors for Cancer Treatment.

Authors:  Mélanie Lambert; Samy Jambon; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Molecules       Date:  2018-06-19       Impact factor: 4.411

Review 3.  Molecular methods for assessment of non-covalent metallodrug-DNA interactions.

Authors:  Andrew Kellett; Zara Molphy; Creina Slator; Vickie McKee; Nicholas P Farrell
Journal:  Chem Soc Rev       Date:  2019-02-18       Impact factor: 54.564

4.  Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA/TA and AT/AT oligonucleotide discrimination.

Authors:  Creina Slator; Zara Molphy; Vickie McKee; Conor Long; Tom Brown; Andrew Kellett
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.